A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present ...
Sep 16, 2020
0
2
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body. However, many patients become resistant to ...
Sep 2, 2020
0
2
According to figures released by Cancer Research UK, melanoma skin cancer deaths have been increasing dramatically in the UK, with the rate rising two and half times since the 1970s.
Aug 20, 2020
0
246
Centenary Institute scientists have discovered that genes on the X chromosome may be key to the improved survival rates of females with melanoma–as compared to their male counterparts. The findings could ultimately lead ...
Aug 13, 2020
0
3
What if you could simply provide a urine sample rather than undergo a painful surgical procedure to find out if your cancer was responding to treatment? It may seem too good to be true, but researchers at Pavol Jozef Šafárik ...
Aug 11, 2020
0
3
A consensus statement published today in JAMA Dermatology by an international group of melanoma researchers evaluates the use of prognostic genetic expression profile (GEP) testing to guide clinical management of patients ...
Jul 29, 2020
0
19
(HealthDay)—Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of a BRAF inhibitor (BRAFi) with or without MEK inhibitor (MEKi) therapy, ...
Jul 22, 2020
0
0
An Online First Accepted Manuscript published in ARRS' American Journal of Roentgenology (AJR) finds that focusing on lung cancer screening (LCS) subjects less likely to remain in the program—those with negative low-dose ...
Jul 17, 2020
0
0
A nationwide group of researchers from the Maurice Wilkins Center (MWC) have recently reported a detailed characterisation of one of the largest melanoma cell line panels ever developed that makes this a resource for research ...
Jul 16, 2020
0
1
Scientists at Sanford Burnham Prebys Medical Discovery Institute have demonstrated the therapeutic potential of PRMT5 inhibitors to sensitize unresponsive melanoma to immune checkpoint therapy. PRMT5 inhibitors are currently ...
Jul 8, 2020
0
113
